Wedbush Issues Pessimistic Forecast for DOC Earnings

Healthpeak Properties, Inc. (NYSE:DOC) – Equities researchers at Wedbush lowered their FY2025 earnings per share estimates for shares of Healthpeak Properties in a research report issued on Friday, February 14th. Wedbush analyst R. Anderson now forecasts that the real estate investment trust will post earnings of $1.85 per share for the year, down from their prior estimate of $1.86. Wedbush currently has a “Outperform” rating and a $24.00 price target on the stock. The consensus estimate for Healthpeak Properties’ current full-year earnings is $1.85 per share. Wedbush also issued estimates for Healthpeak Properties’ FY2026 earnings at $1.96 EPS.

DOC has been the topic of several other reports. Royal Bank of Canada raised their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research note on Wednesday, January 15th. Finally, Mizuho lowered their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties presently has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $19.60 on Monday. The company has a market capitalization of $13.71 billion, a P/E ratio of 55.99, a P/E/G ratio of 2.18 and a beta of 1.15. Healthpeak Properties has a 1-year low of $16.01 and a 1-year high of $23.26. The firm’s 50 day simple moving average is $20.32 and its two-hundred day simple moving average is $21.44. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.31.

Institutional Investors Weigh In On Healthpeak Properties

Several large investors have recently bought and sold shares of DOC. JPMorgan Chase & Co. grew its stake in shares of Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans bought a new position in shares of Healthpeak Properties in the 3rd quarter valued at about $1,880,000. Swedbank AB purchased a new position in Healthpeak Properties in the third quarter worth about $1,832,000. Pathstone Holdings LLC bought a new stake in Healthpeak Properties during the third quarter worth approximately $1,968,000. Finally, Associated Banc Corp purchased a new stake in Healthpeak Properties during the third quarter valued at approximately $10,559,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th will be given a dividend of $0.305 per share. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.23%. The ex-dividend date of this dividend is Friday, February 14th. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.